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We are delighted to announce the return of the International Journal of Diabetes and Metabolism (IJDM) having been interrupted for 2 years. The present first issue will be the first issue under the auspices of the Medical Education Center of Dubai Health Authority, Dubai, UAE.
We are proud to build upon the journal's previous track record under the United Arab Emirates University, Al Ain between 2001 and 2012. We will maintain the same name, National Library of Medicine ID number (101244770) and the ISSN for both online and print versions (print: 1606-7754 and electronic: 2073-5944) and also load up all previous issues and articles on the new website of the journal. We are pleased to have an agreement with an international publisher, Karger Publishers, which will maintain the production of the journal to the international standards of scholarly publishing. We would like to record our appreciation to the editors and advisors who have sustained the journal at any stage of its life.
IJDM publishes reports of clinical and experimental research on diabetes mellitus, endocrinology, and metabolism. Original contributions on morphological, biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolism are all welcome. Reports are published in the form of research and review articles, case reports, discussion papers, letters to the editor, and book reviews. Review articles are normally commissioned by the editors from authors with demonstrable expertise in the field. However, unsolicited reviews may be considered if authors meet the same criteria. The International Journal of Diabetes and Metabolism also publishes abstracts of scientific meetings of reputable organizations. Topical commentaries or perspectives relating to current clinical, professional or scientific issues may either be commissioned or proposed.
We are most grateful to the leadership of the Dubai Health Authority for the initiative of resurrecting the journal under its auspices and the generous financial support. We are committed to the genuine open access movement at the authors' and readers' end. There will be no submission, processing or publishing charges and access to all forms of published material will be free of charge. In the transition period of 2018-2020, the IJDM will be online only. Based on these pledges, we invite all colleagues in clinical practice and related biomedical sciences to reciprocate support as readers, authors, and reviewers.
